Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

First In class oliGo THerapy for Myotonic Dystrophy type 1 (DM1)

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Intellectual Property Rights

the Arthemir Trial

Application/Publication number: EUIPO 018876135
Date: 2024-02-27
Applicant(s): ARTHEX BIOTECH SL

the Arthemir Trial

Application/Publication number: EUIPO 018876135
Date: 2024-02-27
Applicant(s): ARTHEX BIOTECH SL

OLIGONUCLEOTIDES CONJUGATED TO OLEIC ACID AND USES THEREOF

Application/Publication number: 23 174951
Date: 2023-05-23
Applicant(s): ARTHEX BIOTECH SL

MODULATION OF MICRORNAS AGAINST MYOTONIC DYSTROPHY TYPE 1 AND ANTAGONISTS OF MICRORNAS THEREFOR

Application/Publication number: 17 776976
Date: 2017-09-19
Applicant(s): ARTHEX BIOTECH SL

OLIGONUCLEOTIDES CONJUGATED TO OLEIC ACID AND USES THEREOF

Application/Publication number: 23 174951
Date: 2023-05-23
Applicant(s): ARTHEX BIOTECH SL

OLIGONUCLEOTIDES CONJUGATED TO OLEIC ACID AND USES THEREOF

Application/Publication number: 20 24083927
Date: 2024-11-28
Applicant(s): ARTHEX BIOTECH SL

MODULATION OF MICRORNAS AGAINST MYOTONIC DYSTROPHY TYPE 1 AND ANTAGONISTS OF MICRORNAS THEREFOR

Application/Publication number: 17 776976
Date: 2017-09-19
Applicant(s): ARTHEX BIOTECH SL

OLIGONUCLEOTIDES OR ANALOGUES THEREOF FOR THE TREATMENT OF FUCHS ENDOTHELIAL CORNEAL DYSTROPHY

Application/Publication number: 20 24070638
Date: 2024-10-18
Applicant(s): ARTHEX BIOTECH SL

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available

My booklet 0 0